Jane Street Group, LLC Seer, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Seer, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 190,317 shares of SEER stock, worth $460,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares

190,317

Previous 306,039 37.81%

Holding current value

$460,567

Previous $514,000 27.43%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.59 - $2.07 $183,997 - $239,544	-115,722 Reduced 37.81%	190,317 $373,000
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.24 $462,798 - $628,284	280,484 Added 1097.57%	306,039 $514,000
Q1 2024 May 15, 2024	SELL	$1.54 - $2.09 $51,405 - $69,764	-33,380 Reduced 56.64%	25,555 $48,000
Q4 2023 Feb 14, 2024	BUY	$1.47 - $2.22 $86,634 - $130,835	58,935 New	58,935 $114,000
Q2 2023 Aug 14, 2023	SELL	$3.16 - $4.96 $126,229 - $198,132	-39,946 Reduced 40.56%	58,537 $249,000
Q1 2023 May 15, 2023	BUY	$3.6 - $5.88 $269,913 - $440,858	74,976 Added 318.95%	98,483 $380,000
Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $40,551 - $69,171	8,062 Added 52.2%	23,507 $136,000
Q3 2022 Nov 14, 2022	BUY	$7.7 - $13.31 $5,428 - $9,383	705 Added 4.78%	15,445 $120,000
Q2 2022 Aug 16, 2022	BUY	$6.72 - $16.07 $241 - $578	36 Added 0.24%	14,740 $132,000
Q1 2022 May 17, 2022	SELL	$11.88 - $23.4 $53,507 - $105,393	-4,504 Reduced 23.45%	14,704 $224,000
Q4 2021 Feb 15, 2022	BUY	$21.08 - $38.51 $234,009 - $427,499	11,101 Added 136.93%	19,208 $438,000
Q3 2021 Nov 16, 2021	SELL	$27.67 - $45.04 $117,791 - $191,735	-4,257 Reduced 34.43%	8,107 $280,000
Q1 2021 May 18, 2021	BUY	$38.67 - $84.06 $478,115 - $1.04 Million	12,364 New	12,364 $619,000

Others Institutions Holding SEER

# of Institutions

Shares Held

35.4M

Call Options Held

Put Options Held

600

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $142M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Seer, Inc. Transaction History